CNS Summit
| When: | November 10-13 |
| Where: | Boston, MA |
| Booth # | 611 |
OM1 will be at the 2024 CNS Summit conference! Our clinical expertise and integrated evidence approach bring together real-world data, AI, and automated, regulatory-enabled platforms to help researchers fill in gaps along the patient journey from bench to bedside.
Spotlight Panel
| Title: | From Rare to Common: AI and Real-World Data in Identifying Elusive Patients | |
| Date: | Monday, November 11 | |
| Time: | 2:00pm-2:50pm | |
| Chair: | Carl Marci, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience, OM1 | |
| Speakers: |
Joseph Zabinski, PhD, MEM, VP, Head of Commercial Strategy & AI, OM1 Jane Myles, Program Director, DTRA Kemi Olugemo, Chief Medical Officer, Korro Bio |
|
  
|
Identifying patients with rare diseases and those with common yet complex conditions like depression presents unique challenges for healthcare professionals and researchers. In this panel presentation industry experts will explore the transformative role of Artificial Intelligence (AI) and Real-World Data (RWD) in uncovering these hard-to-find patient populations. The discussion will focus on innovative approaches to patient identification, comparing methodologies for rare disease identification with those used in more prevalent but diagnostically challenging conditions like depression. Attendees will gain insights into how AI and RWD are revolutionizing patient discovery, enabling earlier interventions, improving treatment outcomes, and driving forward personalized medicine.
Meet the Team
Carl Marci MD, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience |
Joseph Zabinski, PhD, MEM, VP, Head of Commercial Strategy & AI |
Monika Nowak, Director, RWE and AI Solutions Architect |
Rob Bradley, Senior Director of Partnerships & Alliances |
For additional information or to schedule a meeting with our experts:
